Home / Import refusals / SCS-1338938-6/11/1

FDA Import Refusal SCS-1338938-6/11/1 — Novo Nordisk Inc.

Novo Nordisk Inc. — FEI 2244771

The FDA refused shipment SCS-1338938-6/11/1 from Novo Nordisk Inc. (United States) on December 15, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 15, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1255957 (OAI Fri Feb 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1194065 (NAI Wed Dec 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1013344 (VAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983531 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 968597 (NAI Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 1FX-4157426-0/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0725103-5/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5519360-0/10001/1 (Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0407174-1/20002/1 (Wed Jun 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0407174-1/10002/1 (Wed Jun 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources